Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ciceri, Fabio  [Clear All Filters]
2019
Girmenia, C., Lazzarotto, T., Bonifazi, F., Patriarca, F., Irrera, G., Ciceri, F., Aversa, F., Citterio, F., Cillo, U., Cozzi, E., et al. (2019). Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: a multidisciplinary consensus conference by the Italian GITMO, SITO and AMCLI societies.Clin Transplante13666.
Peccatori, J., Mastaglio, S., Giglio, F., Greco, R., Crocchiolo, R., Patriarca, F., Forno, B., Deola, S., Assanelli, A., Stanghellini, M.Teresa Lup, et al. (2019). Clofarabine and Treosulfan as conditioning for matched related and unrelated HSCT: results from the phase II trial "Clo3o".Biol Blood Marrow Transplant.
Santoro, N., Labopin, M., Ciceri, F., van Lint, M.Teresa, Nasso, D., Blaise, D., Arcese, W., Tischer, J., Bruno, B., Ehninger, G., et al. (2019). Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia over 45 years of age.Cancer.
Marktel, S., Scaramuzza, S., Cicalese, M.Pia, Giglio, F., Galimberti, S., Lidonnici, M.Rosa, Calbi, V., Assanelli, A., Bernardo, M.Ester, Rossi, C., et al. (2019). Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia.Nat Med.
Ferrua, F., Cicalese, M.Pia, Galimberti, S., Giannelli, S., Dionisio, F., Barzaghi, F., Migliavacca, M., Bernardo, M.Ester, Calbi, V., Assanelli, A.Angelo, et al. (2019). Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.Lancet Haematol.
Candoni, A., Rambaldi, A., Fanin, R., Velardi, A., Arcese, W., Ciceri, F., Lazzarotto, D., Lussana, F., Olivieri, J., Grillo, G., et al. (2019). Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Societ.Biol Blood Marrow Transplant.
Beelen, D.Wilhelm, Trenschel, R., Stelljes, M., Groth, C., Masszi, T., Reményi, P., Wagner-Drouet, E.-M., Hauptrock, B., Dreger, P., Luft, T., et al. (2019). Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 .Lancet Haematol.
2018
Raj, K., Eikema, D.-J., McLornan, D.P., Olavarria, E., Blok, H.-J., Bregante, S., Ciceri, F., Passweg, J., Ljungman, P., Schaap, N., et al. (2018). Family mismatched allogeneic stem cell transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of EBMT.Biol Blood Marrow Transplant.
Robin, M., Porcher, R., Ruggeri, A., Blaise, D., Wolschke, C., Koster, L., Angelucci, E., Stölzel, F., Potter, V., Yakoub-Agha, I., et al. (2018). HLA mismatched donors in patients with myelodysplastic syndrome: an EBMT registry analysis.Biol Blood Marrow Transplant.
Shimoni, A., Labopin, M., Lorentino, F., van Lint, M.Teresa, Koc, Y., Gulbas, Z., Tischer, J., Bruno, B., Blaise, D., Pioltelli, P., et al. (2018). Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.Leukemia.
2016
Sessa, M., Lorioli, L., Fumagalli, F., Acquati, S., Redaelli, D., Baldoli, C., Canale, S., Lopez, I.D., Morena, F., Calabria, A., et al. (2016). Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.Lancet.
Nucera, S., Giustacchini, A., Boccalatte, F., Calabria, A., Fanciullo, C., Plati, T., Ranghetti, A., Garcia-Manteiga, J., Cittaro, D., Benedicenti, F., et al. (2016). miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia.Cancer Cell29, 905-921.
Giebel, S., Czyż, A., Ottmann, O., Baron, F., Brissot, E., Ciceri, F., Cornelissen, J.J., Esteve, J., Gorin, N.-C., Savani, B., et al. (2016). Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the acute leukemia working party of the .Cancer.
2015
Girmenia, C., Viscoli, C., Piciocchi, A., Cudillo, L., Botti, S., Errico, A., Sarmati, L., Ciceri, F., Locatelli, F., Giannella, M., et al. (2015). Management of carbapenem resistant klebsiella pneumoniae infections in stem cell transplant recipients: an italian multidisciplinary consensus statement.Haematologica.
2014
Sala, E., Crocchiolo, R., Gandolfi, S., Ventre, M.Bruno, Bramanti, S., Peccatori, J., Sarina, B., Corti, C., Ciceri, F., Santoro, A., et al. (2014). Bendamustine combined to donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant.
Shem-Tov, N., Labopin, M., Moukhtari, L., Ciceri, F., Esteve, J., Giebel, S., Gorin, N.-C., Schmid, C., Shimoni, A., Nagler, A., et al. (2014). Chemotherapy Dose Adjustment for Obese Patients Undergoing Hematopoietic Stem Cell Transplantation: A Survey on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Oncologist.
Locafaro, G., Amodio, G., Tomasoni, D., Tresoldi, C., Ciceri, F., and Gregori, S. (2014). HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia.J Immunol Res2014, 636292.